Breaking Down Relaxo Footwears Limited Financial Health: Key Insights for Investors

Curious whether Relaxo Footwears is a rebound candidate or a cautionary tale for investors? The company reported Q4 FY25 revenue of ₹695 crore (down 6.97% YoY from ₹747 crore) and FY25 revenue of ₹2,789 crore (down 4.27% YoY), with Q2 FY26 revenues slipping further to ₹628.54 crore amid weak mass-market demand and GST timing effects; yet management points to a potential demand uptick after GST on footwear under ₹2,500 fell to 5%, while the firm stayed net cash positive at ₹986.8 million (₹2.13 billion debt vs. ₹3.11 billion cash) and maintained FY25 EBITDA margin of 13.7% despite PAT margin pressure to 6.1% for FY25 and a QoQ PAT margin dip to 5.75% in Q2 FY26-factors that sit alongside a conservative debt-to-equity of ~0.10, a market cap of ₹10,496.50 crore as of 14 Nov 2025 and a stock trading at ₹421.65 (down 40.17% from its 52-week high), setting up a complex risk-reward profile shaped by margin recovery targets, expansion plans (50 new outlets in FY26), the Relaxo Parivaar app rollout, GST tailwinds, and persistent threats from unorganized competition, input-cost volatility and capex-driven cash flow swings that investors will want to probe further

Relaxo Footwears Limited (RELAXO.NS) - Revenue Analysis

Relaxo Footwears has shown a clear downtrend in top-line growth across recent quarters and the full FY25 year, driven largely by subdued mid‑range and mass‑market demand and timing impacts from GST changes. Key headline figures highlight the pressure on sales while core profitability metrics remained relatively stable in some periods.

• Q4 FY25 revenue: ₹695 crore (down 6.97% vs. Q4 FY24 ₹747 crore) - subdued demand in the mid‑range segment.
• FY25 revenue: ₹2,789 crore (down 4.27% vs. FY24 ₹2,914 crore) - consistent annual decline.
• Q2 FY26 revenue: ₹628.54 crore (declined 3.96% quarter‑on‑quarter) - third consecutive quarter of year‑on‑year decline.
• Primary drivers of Q2 FY26 weakness: weak mass market demand and delayed purchases ahead of GST 2.0 implementation.
• Profitability resilience: PBT of ₹65.91 crore reported in Q1 FY25 despite revenue pressures.
• Management expectation: demand revival following GST cut to 5% for footwear priced under ₹2,500, improving competitiveness versus the unorganized sector.

For additional context on ownership and investor mix that could influence demand and strategy, see: Exploring Relaxo Footwears Limited Investor Profile: Who's Buying and Why?

Relaxo Footwears Limited (RELAXO.NS) - Profitability Metrics

• Q4 FY25 net profit margin: 8.1% (vs 8.2% in Q4 FY24) - a small year‑on‑year dip while revenues declined.
• FY25 PAT margin: 6.1% (down from 6.9% in FY24) - a decline of 77 basis points on an annual basis.
• FY25 EBITDA margin: 13.7% - maintained through cost efficiencies and improved working capital.
• Q1 FY26 → Q2 FY26: operating margin contracted from 15.20% to 12.91%; PAT margin compressed from 7.47% to 5.75% quarter‑on‑quarter.
• Management target: +100 bps margin expansion in FY26 via operational efficiencies and premium product mix.

Drivers behind the recent margin moves include operating profitability swings, a modest increase in other income that partially offset Q2 FY26 compression, and continued focus on inventory & receivables management that supported FY25 EBITDA resilience.

• Key short‑term risk: operating margin volatility evidenced by Q2 FY26 contraction; partially mitigated by other income and working‑capital gains.
• Key opportunity: execution of premiumisation and cost levers to realize the targeted 100 bps expansion in FY26.

For broader company context and background on strategy and ownership, see Relaxo Footwears Limited: History, Ownership, Mission, How It Works & Makes Money

Relaxo Footwears Limited (RELAXO.NS) - Debt vs. Equity Structure

• Gross debt (Mar 2025): ₹2.13 billion
• Cash & equivalents (Mar 2025): ₹3.11 billion
• Net cash (Mar 2025): ₹986.8 million (cash minus debt)
• Debt-to-equity ratio (Mar 2025): ~0.10 - indicates low leverage
• Equity ratio (Mar 2025): ~76% - strong equity financing

• Profitability trend: ROE declined from 19% (2021) to 8% (Mar 2025), signaling reduced returns to shareholders despite a strong balance sheet.
• Cash generation: Operating cash flow improved notably in 2025 (₹0.78 bn), reflecting operational efficiency gains.
• Free cash flow volatility: Periodic negative FCF years due to elevated capex have constrained distributable cash despite overall net cash.
• Leverage posture: With a debt-to-equity ~0.10 and net cash ~₹986.8 million, the company has financial flexibility to absorb shocks or fund selective growth.

Relaxo Footwears Limited (RELAXO.NS) - Liquidity and Solvency

Relaxo's reported balance-sheet cash dominance and limited borrowings underpin a solid liquidity and solvency position despite specific current/quick ratios not being disclosed.

• Cash on hand: ₹3.11 billion.
• Total debt: ₹2.13 billion.
• Net cash position: ₹986.8 million (₹3.11B - ₹2.13B).
• Low gross leverage supports flexibility for operations, capex and working capital needs.

• Cash reserves and low debt strengthen the company's ability to meet short-term obligations and absorb demand volatility.
• Management expects demand recovery driven by GST reductions, which could improve cash flows and working-capital dynamics.
• Ongoing cost-efficiency and operational-improvement initiatives are directed at preserving liquidity and enhancing financial stability.
• Capex for FY26 prioritizes efficiency and maintenance-supporting sustainable margin and cash-generation prospects.

For context on strategic direction and guiding principles, see: Mission Statement, Vision, & Core Values (2026) of Relaxo Footwears Limited.

Relaxo Footwears Limited (RELAXO.NS) - Valuation Analysis

• Stock price (14‑Nov‑2025): ₹421.65
• 52‑week high: ₹704.70 (decline of 40.17% from 52‑week high)
• Market capitalization: ₹10,496.50 crore
• Primary drivers of decline: sustained revenue decline and margin pressure in recent quarters
• Management view: expects sales and margins to improve in H2 FY26
• Strategic levers: premium product mix, operational efficiencies, cost discipline

• Valuation sensitivity: improvement in quarterly top‑line and gross/EBIT margins would likely compress valuation discount and support market cap recovery.
• Risk factors: slower than expected recovery in demand, continued input‑cost pressures, and execution delays on premiumisation.
• Monitorables for investors: quarterly revenue trajectory, gross margin trends, operating leverage realization, and commentary versus guidance.

Relaxo Footwears Limited (RELAXO.NS) - Risk Factors

• Competitive pressure and channel fragmentation: Increased competition from low-cost, unorganized players has led to consumer downtrading and price sensitivity, pressuring volumes and ASPs (average selling prices).

• Margin compression and operational inefficiencies: Operating margins have contracted in recent quarters amid higher freight, labour and overheads, and rising brand & distribution spends.

• Input cost volatility: Fluctuations in raw material (PVC, EVA, rubber) and fuel prices have adversely affected gross margins; management commentary and AR notes point to gross-margin erosion during periods of commodity inflation.

• Regulatory and tax changes: GST rate adjustments, slab reclassifications or compliance costs can impact pricing strategy, consumer demand elasticity and working capital.

• Expansion and capex execution risk: Plant capacity additions, supply-chain scaling and distribution expansion can strain free cash flow if demand does not scale as forecast; delays or cost overruns can pressurize balance sheet ratios.

• Macroeconomic and market volatility: Economic slowdowns reduce discretionary footwear spend; currency swings and inflation can amplify cost and demand shocks.

• Operational specifics to monitor: inventory days, receivables, channel inventory, SKU rationalization, and uptake of direct-to-consumer vs wholesale channels-any deterioration signals higher working-capital stress and margin dilution.

• Event risks: A sudden GST classification change, sustained raw-material inflation, or a demand shock in rural markets would meaningfully affect quarterly profitability and growth guidance.

Relaxo Footwears Limited (RELAXO.NS) - Growth Opportunities

• Relaxo Parivaar app: digital engagement tool aimed at improving retailer ordering frequency, inventory turns and promotional alignment across ~100,000+ touchpoints in the dealer/retailer network (pilot → phased roll‑out to all partners).
• Store expansion: management plan to open 50 new retail outlets in FY26 to build physical brand presence and support premium product displays.
• Premiumisation & margins: higher mix of premium products combined with operating-leverage and cost-efficiency programs is expected to expand gross and EBITDA margins over the next 12-24 months.
• GST headroom: reduction in GST for footwear priced under ₹2,500 (threshold cited by authorities) is likely to stimulate demand in the organized sector and improve price competitiveness vs. unorganized players.
• Capex and sustainability: FY26 capex earmarked for new product development, energy-efficient manufacturing upgrades and packaging improvements to lower unit costs and carbon intensity.
• Channel & pricing discipline: strategic measures to control price undercutting on modern trade and marketplace reforms to protect brand value and share in high-margin segments.

• Supply‑chain optimization: factory rationalisation and modernization to reduce lead times and working capital.
• SKU rationalization and premium SKUs: higher ASP (average selling price) target in casual and athleisure ranges.
• E‑commerce reforms: tightened marketplace price parity and brand stores to reduce discount-driven churn.

• Base case: Revenue CAGR of 7-10% over FY25-FY27 driven by store rollouts + organic growth; EBITDA margin +100 bps.
• Upside case: Faster Parivaar adoption + GST tailwind → Revenue CAGR 10-14%; EBITDA margin +200-250 bps from premium mix and energy savings.